Study Description A5384 is a trial for people who have or might have tuberculous meningitis (TBM). TBM is an infectious disease...
1077FF is a randomized strategy trial, which is part of the PROMISE studies (1077BF, 1077FF, P1084s, and 1077HS). The Promoting...
Objectives: Primary: To develop a highly predictive algorithm that identifies TB patients who will be cured by treatment...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
ACTG A5324 is a phase IV randomized, double-blinded, placebo-controlled study to assess the efficacy of adding Maraviroc (MVC)...
